(Q34417853)

2 August 2017

Excretion of tiapamil in breast milk (English)

1 reference

2 August 2017

Hartmann D

1

1 reference

2 August 2017

Lunell NO

series ordinal

2

1 reference

2 August 2017

Friedrich G

series ordinal

3

1 reference

2 August 2017

Rane A

series ordinal

4

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 August 1988

1 reference

British Journal of Clinical Pharmacology

2 August 2017

1 reference

2 August 2017

26

1 reference

2 August 2017

183-186

1 reference

2 August 2017

2

1 reference

Fat content of expressed breast milk: a case for quality control

2 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386526

Effect of a new calcium antagonist, tiapamil, in hypertension of the elderly

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386526

Determinants and consequences of drug excretion in breast milk

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386526

The Distribution of Some Commonly Used Drugs in Human Breast Milk

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386526

Pharmacokinetic pitfalls in the estimation of the breast milk/plasma ratio for drugs

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386526

Verapamil and breast-feeding

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386526

Factors affecting the milk-to-plasma drug concentration ratio in lactating women: physical interactions with protein and fat.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386526

A new Ca++ antagonist, Ro 11-1781, and its metabolites. Synthesis and physicochemical properties

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386526

Tiapamil, a new calcium antagonist. 2. Further pharmacological characterization and toxicology.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386526

Tiapamil, a new calcium antagonist. 1. Demonstration of calcium antagonistic activity and related studies.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386526

Infant growth and human milk requirements. A fresh approach

27 October 2018

1 reference

12 December 2020

Pharmacokinetics and metabolism of tiapamil

1 reference

12 December 2020

Long-term tiapamil treatment of patients with angina pectoris

1 reference

12 December 2020

Excretion of verapamil in human milk

1 reference

12 December 2020

[Initial experiences with the calcium antagonist tiapamil in the treatment of arterial hypertension]

1 reference

12 December 2020

Determination of tiapamil and of its two main metabolites in plasma and in urine by high-performance liquid chromatography

1 reference

12 December 2020

Drug Distribution Within Human Milk Phases

1 reference

12 December 2020

Comparative pharmacokinetics and cardiovascular effects of tiapamil in healthy volunteers and patients with hepatic cirrhosis

1 reference

12 December 2020

Verapamil and norverapamil in plasma and breast milk during breast feeding

1 reference

12 December 2020

10.1111/J.1365-2125.1988.TB03385.X

Identifiers

DOI

1 reference

2 August 2017

1 reference

2 August 2017

1 reference